Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
The Novartis group has announced the closure of its cell and gene therapy production site in Les Ulis (Essonne), which employs 209 people. Novartis bought the site in 2019 from the French Fractionation and Biotechnology Laboratory (LFB). The Swiss group had received 800,000 euros in subsidies from the stimulus plan to modernise the site. The management announced this project to cease its CAR-T cell therapy production activities to employee representatives on 16 February. The information and consultation procedure for the implementation of a job protection plan began on 22 February. In accordance with the legislation, Novartis is required to look for a buyer before closing the site. Without a buyer by 22 June, 149 people will be made redundant then, and the remaining 60 - by the end of 2023. At the end of 2022, Novartis had around 2,900 employees in France, including 1,436 jobs corresponding to medical sales representatives and the head office in Rueil-Malmaison (Hauts-de-Seine), with the remainder divided between two production sites. In Huningue (Alsace), around 800 people manufacture monoclonal antibodies, while in Les Ulis, 200 employees manufacture Kymriah, a cell therapy known as 'CAR T-Cell'. Novartis has alrerady announced a restructuring in January 2023, with 400 job cuts in France (FR-Novartis-2023a). At the day of the anouncement the management explained the two production sites located in Huningue and Les Ulis will not be affected.
Eurofound (2023), Novartis CellForCure, Closure in France, factsheet number 108625, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/108625.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...
